German site
Pharmanovia signs novel biologic in-licensing agreement
PRESS RELEASE – FOR TRADE, MEDICAL AND BUSINESS MEDIA ONLY BASILDON, UK, 19 November 2024 Pharmanovia,...
More informationPharmanovia acquires exclusive rights to treatment for Parkinson’s disease
PRESS RELEASE – FOR TRADE, BUSINESS AND MEDICAL MEDIA ONLY BASILDON, UK, Monday 7 October 2024 ...
More informationNew Pharmanovia study results reveal chloral hydrate noticeably improves severe insomnia within two weeks
FOR MEDICAL TRADE AND BUSINESS MEDIA ONLY BASILDON, UK, 30 September 2024 Pharmanovia, a global pharmaceutical...
More informationPharmanovia partners with Echo Therapeutics for promotional activities in Australia
For immediate release, 20TH May, 2024 Pharmanovia, the lifecycle management company, has today announced that it...
More informationPharmanovia CEO, James Burt appointed Chair of Medicines for Europe’s Value Added Medicines (VAM) sector group
PRESS RELEASE (business and pharma trade only) FOR IMMEDIATE RELEASE, Basildon, 9 November 2023 Pharmanovia, a...
More informationPharmanovia joins IRDiRC task force to publish drug repurposing guidebook aimed at improving care for people living with rare disease
PRESS RELEASE (Pharma trade media only) London, 1 November 2023 THE GUIDEBOOK HAS BEEN PUBLISHED IN...
More informationPharmanovia acquires global central nervous system (CNS) portfolio from Sanofi
FOR TRADE, BUSINESS AND MEDICAL MEDIA ONLY Basildon, UK, 18 September 2023 Pharmanovia, a global pharmaceutical...
More informationGlobal pharmaceutical leader sets sight on sustainable future for the sector by setting challenging SBTI Net Zero target
Pharmanovia unveils results in new Sustainability Report and pledges commitment to new environmental and sustainability targets...
More informationPharmanovia enters new chemical entity licensing agreement with Stealth BioTherapeutics to market and further develop a potential novel treatment for Barth Syndrome
PRESS RELEASE: FOR BUSINESS AND TRADE MEDIA ONLY BASILDON, UK, 30 MAY 2023 Pharmanovia, a global...
More informationFor all media enquiries please contact: communications@pharmanovia.com